Financials

  • Market Capitalization 259.39 M
  • Employee 122
  • Founded 2020
  • CEO N/A
  • Website www.invivyd.com
  • Headquarter Delaware, United States
  • FIGI BBG00W4ML039
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.81
ratio cours/chiffre d'affaires
3.28

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3413
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
4.63 USD+1.98%-8.86%+19.33%+53.82%263.95 M USD
3420
SRZN
Surrozen, Inc. - Common Stock
22.20 USD+0.82%-5.61%-3.98%+81.08%260.93 M USD
3431
MGNX
MacroGenics, Inc. - Common Stock
4.04 USD+1.25%-2.88%+8.60%+132.18%257.35 M USD
3446
NMRA
Neumora Therapeutics, Inc. - Common Stock
1.33 USD0.00%-11.33%-17.90%-23.12%249.90 M USD

Nouvelles